Oct 30, 2025 08:30AM Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3

Sep 30, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)

Sep 3, 2025 08:03AM Connect Biopharma ends ADR program, lists ordinary shares on NASDAQ

Jul 22, 2025 09:15AM Connect Biopharma adds Jim Schoeneck to board of directors

Jul 22, 2025 08:55AM Northland Reiterates Outperform Rating on Connect Biopharma Holdings Ltd (CNTB)

Jul 21, 2025 09:02AM Connect Biopharma plans to terminate ADR program and list ordinary shares

Jul 9, 2025 09:02AM Simcere submits drug application for rademikibart in China

Jun 13, 2025 09:01AM Connect Biopharma (CNTB) Presents Data Supporting Rademikibart

Jun 10, 2025 04:38PM Connect Biopharma (CNTB) Files $300M Mixed Shelf

May 13, 2025 09:08AM Connect Biopharma (CNTB) Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

Apr 11, 2025 09:00AM Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Apr 1, 2025 09:02AM Connect Biopharma (CNTB) Announces Positive Type C Meeting with the FDA for Rademikibart

Apr 1, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)

Mar 31, 2025 04:05PM Connect Biopharma (CNTB) Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart

Mar 28, 2025 04:06PM Connect Biopharma (CNTB) Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

Sep 6, 2024 06:56AM H.C. Wainwright Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)

Jun 12, 2024 04:15PM Connect Biopharma (CNTB) Appoints Barry Quart as CEO, David Szekeres as President